The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with ...

Recent research takes aim at the a variant in gene SCN1B, which causes a severe form of developmental epileptic encephalopathy.

The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with drug-resistant mesial temporal lobe epilepsy SAN FRANCISCO, Feb.

Subscribe for FREE Mice without the SCN1B gene experience seizures and 100 percent mortality just three weeks after birth. Using mouse models, the investigative team, led by Chunling Chen, M.D., and ...

Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...

By Dr. Liji Thomas, MD Researchers successfully use an adeno-associated viral vector to restore brain function in a mouse ...

Connecticut lawmakers are weighing a bill on authorizing electric shock therapy either with or without a person’s consent.

UK Medical Eligibility Criteria for Contraceptive Use Category 1: A condition for which there is no restriction for the use of the contraceptive method with the condition or in that circumstance.

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as ...